 TÜBINGEN, GERMANY and BOSTON, MA ACCESSWIRE November 10, 2022 CureVac N.V. NASDAQ:CVAC, a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid mRNA, will report financial results, and provide business updates for the third quarter of 2022 on Wednesday, November 16, 2022. 